Latest updates
View our press releases and follow Diasome’s path to Phase III Clinical Trials.
Press Release
June 10, 2019
Diasome’s Hepatocyte Directed Vesicle (HDV) Technology Met Primary Endpoint in Phase 2b Trial in Type 1 Diabetes
Learn More
Press Release
June 10, 2019
Diasome’s Hepatocyte Directed Vesicle (HDV) Technology Met Primary Endpoint in Phase 2b Trial in Type 1 Diabetes
Learn More
Press Release
June 10, 2019
Diasome’s Hepatocyte Directed Vesicle (HDV) Technology Met Primary Endpoint in Phase 2b Trial in Type 1 Diabetes
Learn More
Press Release
May 29, 2019
Diasome Announces Presentations at the American Diabetes Association’s 79th Scientific Sessions
Learn More
Press Release
May 29, 2019
Diasome Announces Presentations at the American Diabetes Association’s 79th Scientific Sessions
Learn More
Press Release
May 29, 2019
Diasome Announces Presentations at the American Diabetes Association’s 79th Scientific Sessions
Learn More
News Article
April 29, 2019
Diasome's Father-Son Developing Nanotech to Improve Insulin Effectiveness
Learn More
News Article
April 29, 2019
Diasome's Father-Son Developing Nanotech to Improve Insulin Effectiveness
Learn More
News Article
April 29, 2019
Diasome's Father-Son Developing Nanotech to Improve Insulin Effectiveness
Learn More
Interview
April 18, 2019
Diasome's Liver Targeted Insulin
Learn More
Interview
April 18, 2019
Diasome's Liver Targeted Insulin
Learn More
Interview
April 18, 2019
Diasome's Liver Targeted Insulin
Learn More
Press Release
March 28, 2019
First Patient Enrolled in Phase 2 Study of Hepatocyte Directed Vesicle Technology for People with Type 1 Diabetes
Learn More
Press Release
March 28, 2019
First Patient Enrolled in Phase 2 Study of Hepatocyte Directed Vesicle Technology for People with Type 1 Diabetes
Learn More
Press Release
March 28, 2019
First Patient Enrolled in Phase 2 Study of Hepatocyte Directed Vesicle Technology for People with Type 1 Diabetes
Learn More
Interview
February 28, 2019
Developing Smarter Insulin to Treat Diabetes
Learn More
Interview
February 28, 2019
Developing Smarter Insulin to Treat Diabetes
Learn More
Interview
February 28, 2019
Developing Smarter Insulin to Treat Diabetes
Learn More
Press Release
February 14, 2019
Diasome Pharmaceuticals, Inc. provides 16-month period company update
Learn More
Press Release
February 14, 2019
Diasome Pharmaceuticals, Inc. provides 16-month period company update
Learn More
Press Release
February 14, 2019
Diasome Pharmaceuticals, Inc. provides 16-month period company update
Learn More
Press Release
July 5, 2017
Diasome Pharmaceuticals, Inc. Receives Funding From JDRF T1D Fund
Learn More
Press Release
July 5, 2017
Diasome Pharmaceuticals, Inc. Receives Funding From JDRF T1D Fund
Learn More
Press Release
July 5, 2017
Diasome Pharmaceuticals, Inc. Receives Funding From JDRF T1D Fund
Learn More
Press Release
July 5, 2017
Diasome Pharmaceuticals, Inc. Receives Funding Led By Medicxi
Learn More
Press Release
July 5, 2017
Diasome Pharmaceuticals, Inc. Receives Funding Led By Medicxi
Learn More
Press Release
July 5, 2017
Diasome Pharmaceuticals, Inc. Receives Funding Led By Medicxi
Learn More
Interview
September 17, 2016
2016 Diabetes Symposium in Boston, Robert Geho interviewed by Diabetes in Control publisher Steve Freed
Learn More
Interview
September 17, 2016
2016 Diabetes Symposium in Boston, Robert Geho interviewed by Diabetes in Control publisher Steve Freed
Learn More
Interview
September 17, 2016
2016 Diabetes Symposium in Boston, Robert Geho interviewed by Diabetes in Control publisher Steve Freed
Learn More
News Article
August 28, 2016
After Decades of work, Diasome's insulin additive enters 200-patient trial
Learn More
News Article
August 28, 2016
After Decades of work, Diasome's insulin additive enters 200-patient trial
Learn More
News Article
August 28, 2016
After Decades of work, Diasome's insulin additive enters 200-patient trial
Learn More
Press Release
July 29, 2016
Diasome announces dosing of first type 1 diabetes patient in randomized phase 2b clinical trial of injectable hepatocyte direct vesicle (HDV) technology with insulin
Learn More
Press Release
July 29, 2016
Diasome announces dosing of first type 1 diabetes patient in randomized phase 2b clinical trial of injectable hepatocyte direct vesicle (HDV) technology with insulin
Learn More
Press Release
July 29, 2016
Diasome announces dosing of first type 1 diabetes patient in randomized phase 2b clinical trial of injectable hepatocyte direct vesicle (HDV) technology with insulin
Learn More
Media Relations
Cherilyn Cecchini, M.D.
LifeSci Communications
+1.646.876.7110
ccecchini@lifescicomms.com
